Peps
What is Hexarelin?
Hexarelin is a synthetic six-residue growth-hormone secretagogue. The selected early human experiment measured hormone release, rather than muscle gain or injury recovery.
Biological role or research focus
Human endocrine physiology.
The study did not establish changes in strength, body composition, injury recovery, or long-term clinical outcomes. Twelve volunteers and an acute observation window cannot resolve sustained benefit or safety.
Role reference: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Names you may encounter
Examorelin · EP-23905
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Synthetic hexapeptide growth-hormone secretagogue
- Research focus
- Human endocrine physiology
- Featured evidence
- Human physiology study
- Source check
- October 4, 2026
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Molecular structure
How Hexarelin works
Hexarelin stimulates growth-hormone release. In the selected study, the acute hormonal response was the measured outcome; it cannot be substituted for a demonstrated functional benefit.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Clinical context & research status
The evidence featured here is short-term experimental endocrine physiology. It does not establish a treatment for muscle growth, poor sleep, or tendon injuries.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human physiology study · 1994
Early healthy-volunteer physiology study
Did hexarelin stimulate acute growth-hormone release?
- Population / model
- 12 healthy adult men.
- Study design
- Blinded placebo-controlled study examining acute hormone responses across studied exposures.
- Main finding
- Growth hormone rose after hexarelin, peaked at roughly 30 minutes, and returned toward baseline by about 240 minutes.
- Limits & context
- The study did not establish changes in strength, body composition, injury recovery, or long-term clinical outcomes. Twelve volunteers and an acute observation window cannot resolve sustained benefit or safety.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway. ↗
International heart journal · 2017 Apr 6 · Journal Article
We are ageing. ↗
BioMed research international · 2014 · Journal Article, Review
Read available full text ↗
Growth hormone-releasing peptides. ↗
European journal of endocrinology · 1997 May · Journal Article, Research Support, Non-U.S. Gov't, Review
The cardiovascular action of hexarelin. ↗
Journal of geriatric cardiology : JGC · 2014 Sep · Journal Article, Review
Read available full text ↗
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
What the featured evidence can tell us
An acute hormone-release study cannot establish safety during repeated exposure. Endocrine effects and possible effects on other hormone pathways need separate assessment.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Identity, route, and evidence limits
The study did not establish changes in strength, body composition, injury recovery, or long-term clinical outcomes. Twelve volunteers and an acute observation window cannot resolve sustained benefit or safety.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
2 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Biohackingturkey
Hexarelin Nedir? Büyüme Hormonunu Nasıl Tetikler? ↗
Title match · Captions not indexed
Biohackingturkey
Hexarelin Peptidi: Ne İşe Yarar ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
Hexarelin (10 mg)
PSPeptides · Vendor-labeled research use only
$59.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Does a higher growth-hormone measurement prove more muscle?
- What population, comparator, and route were actually studied?
- The study did not establish changes in strength, body composition, injury recovery, or long-term clinical outcomes. Twelve volunteers and an acute observation window cannot resolve sustained benefit or safety.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Does a higher growth-hormone measurement prove more muscle?
No. A hormone measurement is a surrogate outcome. Muscle strength, function, and adverse effects need direct measurement in an appropriate trial.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
Does this page establish a supplier’s product quality?
No. A publication describes its own tested material. It does not verify a supplier listing, batch identity, purity, or clinical suitability.
Source: Growth hormone-releasing activity of hexarelin in humans. A dose-response study. · 1994 ↗
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.